A $300 million manufacturing and research and development facility has been opened by Siemens Healthineers at its East Walpole campus in Massachusetts. The facility, which will manufacture laboratory diagnostic devices, has created over 275 jobs as of December and is expected to employ 700 new workers by 2026.
Grail -- a Menlo Park, Calif.-based cancer testing startup backed by high-profile investors, including Amazon founder Jeff Bezos and Microsoft co-founder Bill Gates -- could launch an initial public offering in the US as early as next year, depending on stock market conditions, sources say. Grail is developing a test for early detection of a wide range of cancers and had considered a Hong Kong listing.
Patients with severe hepatic steatosis who also had thrombocytopenia were found to be at a higher risk for cardiovascular-related mortalities and all-cause mortality. The abstract was presented at the American Association for the Study of Liver Diseases' 2018 Liver Meeting.
Correctly distinguishing in vitro from in vivo hemolysis is clinically important because the latter could be a sign of various pathological conditions, including some that could be life-threatening if untreated, writes John Mitsios, assistant director of the special coagulation laboratory at BioReference Laboratories. In vivo hemolysis can be caused by several factors including blood cell defects, or autoimmune hemolytic anemia and hemolysis after an incompatible transfusion. In vitro hemolysis usually results from pre-analytical factors such as blood drawing and specimen handling.
As the number of Ebola virus infections nears 500 in the Democratic Republic of Congo, South Sudan is preparing to begin a vaccination campaign among health care workers, according to the World Health Organization. South Sudan, Uganda and Rwanda, all of which border the DRC, were identified as being "at very high risk" of Ebola by the WHO.
Researchers with the Medical University of Vienna found hepatitis C virus in the rectal and nasal fluids of patients with high viral loads, even when blood was not present in those bodily fluids. The findings were presented at a meeting of the American Association for the Study of Liver Diseases.
Egyptian Health and Population Minister Hala Zayed said that 15.5 million people have been screened for hepatitis C as part of the country's 100 Million Healthy Lives initiative. Egypt has the highest prevalence of HCV globally, and the campaign aims to screen adults ages 19 to 59.
AusDiagnostics, an Australian startup, said CE-IVD marking has been granted to its assay for hemochromatosis. The polymerase chain reaction test detects mutant and wild-type alleles of the protein hFE.
- Page 1